New Research Demonstrates the Clinical Utility with Daxor's Blood Volume Analyzer (BVA-100®) in Critical CareGlobeNewsWire • 02/04/21
DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH L1 ENTERPRISES GOVERNMENT DISTRIBUTORGlobeNewsWire • 01/13/21
Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.GlobeNewsWire • 12/10/20
New Research Shows Daxor’s BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020GlobeNewsWire • 10/06/20
New Research Demonstrates Daxor BVA-100® Blood Test Provides “Extremely Cost-Effective” Improvement in Patient Life Span at the Heart Failure Society of America Annual Scientific Meeting 2020GlobeNewsWire • 10/05/20
New Data Released from the Mayo Clinic Utilizing Daxor’s BVA-100® Test Highlights Value of Daxor’s Diagnostic at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020GlobeNewsWire • 10/02/20
Daxor Corporation to Exhibit and Showcase Compelling New Data at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020 on the Value of BVA-100®GlobeNewsWire • 09/28/20
DAXOR ANNOUNCES COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH THE UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCESGlobeNewsWire • 08/04/20
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct OfferingGlobeNewsWire • 07/20/20
DAXOR ANNOUNCES PROSPECTIVE RANDOMIZED CONTROL TRIAL AT DUKE UNIVERSITY MEDICAL CENTER TO GUIDE VOLUME TREATMENT IN HEART FAILURE PATIENTSGlobeNewsWire • 07/16/20
Daxor Announces Initiation of First-of-Its-Kind Multicenter BVA-100® Study in Hospitalized Patients With COVID-19GlobeNewsWire • 07/15/20
DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH AMERICAN MEDICAL DEPOT GOVERNMENT DISTRIBUTORGlobeNewsWire • 07/08/20
Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq.GlobeNewsWire • 06/30/20
Daxor Corporation, CEO Michael Feldschuh to Participate in Maxim Group’s COVID-19 Virtual Conference on May 27, 2020GlobeNewsWire • 05/26/20
Daxor’s BVA-100® Published in Novel Study in American Heart Association Journal - CirculationGlobeNewsWire • 05/22/20
Daxor Awarded $1.1 Million Contract from United States Department of Defense (DOD) for Rapid Portable Blood Volume AnalyzerGlobeNewsWire • 04/23/20
Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 PatientGlobeNewsWire • 03/20/20